Zura Bio Limited said it has appointed Sandeep Kulkarni as chief executive, effective Wednesday. The clinical-stage biotechnology company said Kulkarni will continue serving as a director. Kulkarni ...
Leadership transition follows a year of doubled revenue and rising demand for low-carbon pavement preservation ...
Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of ...
Shares of Zura Bio climbed after the company appointed Sandeep Kulkarni as its chief executive. Shares were up 12% to $5.60 on Wednesday afternoon after hitting a 52-week high of $5.87 earlier in the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...
Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities. The converted common stock is included in the company’s total 165 million outstanding ...
MINNEAPOLIS, Oct. 22, 2025 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, is taking center stage this week at the Norman E. Borlaug International Dialogue, part of ...
Abbott to lead the sustainable agriculture company through global growth as it transforms agriculture with its patented crop nutrition innovations and upends the $190B nitrogen market 1 Company ...
John Crowley, the longtime leader of rare disease drug developer Amicus Therapeutics and a board member of the Biotechnology Innovation Organization, will become the trade organization’s new president ...
Kronos Bio (NASDAQ:KRON) announced Wednesday its CFO Deborah Knobelman will become the company’s interim Chief Executive Officer on Dec. 3, replacing Norbert Bischofberger, who will resign as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results